AI Article Synopsis

  • The study found that human cytochrome P450 (P450) 2A13 interacts with multiple polycyclic aromatic hydrocarbons (PAHs) to produce Type I binding spectra, while P450 2A6 shows selective interaction only with certain PAHs.
  • P450 1B1 is recognized for oxidizing carcinogenic PAHs and demonstrated reverse Type I binding with several PAHs, indicating its critical role in metabolizing potential carcinogens.
  • Both P450 2A13 and 2A6 were highly effective in activating procarcinogens like 2-aminofluorene and 2-aminoanthracene, supported by molecular docking studies showing their binding in active

Article Abstract

Human cytochrome P450 (P450) 2A13 was found to interact with several polycyclic aromatic hydrocarbons (PAHs) to produce Type I binding spectra, including acenaphthene, acenaphthylene, benzo[c]phenanthrene, fluoranthene, fluoranthene-2,3-diol, and 1-nitropyrene. P450 2A6 also interacted with acenaphthene and acenaphthylene, but not with fluoranthene, fluoranthene-2,3-diol, or 1-nitropyrene. P450 1B1 is well-known to oxidize many carcinogenic PAHs, and we found that several PAHs (i.e., 7,12-dimethylbenz[a]anthracene, 7,12-dimethylbenz[a]anthracene-5,6-diol, benzo[c]phenanthrene, fluoranthene, fluoranthene-2,3-diol, 5-methylchrysene, benz[a]pyrene-4,5-diol, benzo[a]pyrene-7,8-diol, 1-nitropyrene, 2-aminoanthracene, 2-aminofluorene, and 2-acetylaminofluorene) interacted with P450 1B1, producing Reverse Type I binding spectra. Metabolic activation of PAHs and aryl- and heterocyclic amines to genotoxic products was examined in Salmonella typhimurium NM2009, and we found that P450 2A13 and 2A6 (as well as P450 1B1) were able to activate several of these procarcinogens. The former two enzymes were particularly active in catalyzing 2-aminofluorene and 2-aminoanthracene activation, and molecular docking simulations supported the results with these procarcinogens, in terms of binding in the active sites of P450 2A13 and 2A6. These results suggest that P450 2A enzymes, as well as P450 Family 1 enzymes including P450 1B1, are major enzymes involved in activating PAHs and aryl- and heterocyclic amines, as well as tobacco-related nitrosamines.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3713097PMC
http://dx.doi.org/10.1021/tx3004906DOI Listing

Publication Analysis

Top Keywords

p450 2a13
16
p450 1b1
16
heterocyclic amines
12
p450
12
2a13 2a6
12
fluoranthene fluoranthene-23-diol
12
metabolic activation
8
polycyclic aromatic
8
aromatic hydrocarbons
8
type binding
8

Similar Publications

1-Nitropyrene Metabolism and Health Risk: Identification of Key Enzymes, Pathways, and Metabolites Using a Multimethod Approach.

Environ Health (Wash)

December 2023

Guangdong-Hong Kong-Macao Joint Laboratory for Contaminants Exposure and Health, Guangdong Key Laboratory of Environmental Catalysis and Health Risk Control, Institute of Environmental Health and Pollution Control, Guangdong University of Technology, Guangzhou 510006, China.

Polycyclic aromatic hydrocarbon (PAH) derivatives have a widespread presence in the environment and even the human body, but their metabolism and potential risk remain unclear. In this study, we used molecular dynamics simulations and density functional theory to calculate the metabolic mechanism of 1-nitropyrene (1-NP), an important PAH derivative. The results showed that cytochrome P450 enzymes (CYPs) can metabolize 1-NP, with CYP 2A13 and CYP 2E1 being important enzyme isoforms, because they had lower binding affinities (-16.

View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on CYP2A13, a monooxygenase enzyme involved in breaking down nicotine and other compounds, which has genetic variants that reduce its activity.
  • Researchers used molecular dynamics simulations to analyze the three-dimensional structures of CYP2A13 variants compared to the normal form (wild type) over 1000 ns.
  • Results showed that certain variants altered interactions with heme and affected the enzyme's structure, leading to decreased enzymatic activity, providing insights into the molecular reasons behind this reduction.
View Article and Find Full Text PDF

As a potential means for smoking cessation and consequently prevention of smoking-related diseases and mortality, in this study, our goal was to investigate the inhibition of nicotine metabolism by P450 2A6. Smoking is the main cause of many diseases and disabilities and harms nearly every organ of the body. As reported by the Centers for Disease Control and Prevention (CDC), more than 16 million Americans are living with diseases caused by smoking.

View Article and Find Full Text PDF

Newly Identified Tree Shrew 2A13 is Expressed in Liver and Lung and Encodes a Functional Drug-Metabolizing Enzyme Similar to Dog 2A13 and Pig 2A19.

Drug Metab Dispos

May 2023

Joint Faculty of Veterinary Medicine, Kagoshima University, Kagoshima, Japan (G.U., Y.U.); Showa Pharmaceutical University, Tokyo, Japan (Y.N., N.M., H.Y.); School of Veterinary Medicine, Kitasato University, Aomori, Japan (H.K.); and Transboundary Animal Diseases Center and Laboratory of Animal Hygiene, Joint Faculty of Veterinary Medicine, Kagoshima University, Kagoshima, Japan (K.T.-K.)

The tree shrew, a non-rodent primate-like species, is used in various fields of biomedical research, including hepatitis virus infection, myopia, depression, and toxicology. Recent genome analysis found that the numbers of cytochrome P450 (P450 or ) genes are similar in tree shrews and humans and their sequence identities are high. Although the P450s are a family of important drug-metabolizing enzymes, they have not yet been fully investigated in tree shrews.

View Article and Find Full Text PDF

Both tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and nicotine can be metabolized by cytochrome P450 2A13 (CYP2A13). Previous studies have shown that nicotine has a potential inhibitory effect on the toxicity of NNK. However, due to the lack of CYP2A13 activity in conventional lung cell lines, there had been no systematic in vitro investigation for the key target organ, the lung.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!